These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 826923)

  • 1. A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF.
    Alfredsson G; Wode-Helgodt B; Sedvall G
    Psychopharmacology (Berl); 1976 Jul; 48(2):123-31. PubMed ID: 826923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
    Alfredsson G; Bjerkenstedt L; Edman G; Härnryd C; Oxenstierna G; Sedvall G; Wiesel FA
    Acta Psychiatr Scand Suppl; 1984; 311():49-74. PubMed ID: 6199949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.
    Wode-Helgodt B; Alfredsson G
    Psychopharmacology (Berl); 1981; 73(1):55-62. PubMed ID: 6785790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
    Wode-Helgodt B; Borg S; Fyrö B; Sedvall G
    Acta Psychiatr Scand; 1978 Aug; 58(2):149-73. PubMed ID: 358755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma nor1-chlorpromazine concentrations: effects of age, race, and sex.
    Young RC
    Ther Drug Monit; 1986; 8(1):23-6. PubMed ID: 3961892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of chlorpromazine and its major metabolites by gas chromatography/mass spectrometry: application to biological fluids.
    Gruenke LD; Craig JC; Klein FD; Nguyen TL; Hitzemann BA; Holaday JW; Loh HH; Braff L; Fischer A; Glick ID
    Biomed Mass Spectrom; 1985 Dec; 12(12):707-13. PubMed ID: 2936401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
    Sgaragli G; Ninci R; Della Corte L; Valoti M; Nardini M; Andreoli V; Moneti G
    Drug Metab Dispos; 1986; 14(2):263-6. PubMed ID: 2870904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a plasma level of chlorpromazine help?
    Van Putten T; May PR; Jenden DJ
    Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution and metabolism of chlorpromazine in rats and the relationship to effects on cerebral monoamine metabolism.
    Wiesel FA; Alfredsson G
    Eur J Pharmacol; 1976 Dec; 40(2):263-72. PubMed ID: 991935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of radioimmunoassay for chlorpromazine.
    Kawashima K; Dixon R; Spector S
    Eur J Pharmacol; 1975; 32(02):195-202. PubMed ID: 1149806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method.
    Swahn C-G ; Sandgárde B; Wiesel F-A ; Sedvall G
    Psychopharmacology (Berl); 1976 Jul; 48(2):147-53. PubMed ID: 826926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How long does chlorpromazine last?
    Lacoursiere RB; Spohn HE
    J Nerv Ment Dis; 1976 Oct; 163(4):267-75. PubMed ID: 972329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a side effect as a qualitative indicator of plasma chlorpromazine levels.
    Chetty M; Gouws E; Miller R; Moodley SV
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):77-82. PubMed ID: 10082231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important metabolites to measure in pharmacodynamic studies of chlorpromazine.
    Chetty M; Moodley SV; Miller R
    Ther Drug Monit; 1994 Feb; 16(1):30-6. PubMed ID: 8160251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of seven selected antipsychotic drugs in human plasma using microextraction in packed sorbent and gas chromatography-tandem mass spectrometry.
    da Fonseca BM; Moreno IE; Barroso M; Costa S; Queiroz JA; Gallardo E
    Anal Bioanal Chem; 2013 May; 405(12):3953-63. PubMed ID: 23314486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
    Makanjuola RO; Dixon PA; Oforah E
    Trop Geogr Med; 1988 Jan; 40(1):31-3. PubMed ID: 3381314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein binding of chlorpromazine in cerebrospinal fluid and serum.
    Alfredsson G; Sedvall G
    Int Pharmacopsychiatry; 1980; 15(5):261-9. PubMed ID: 7263148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
    Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG
    Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.